Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Amoxicillin, Clavulanic Acid
Vetoquinol UK Ltd
QJ01CR02
Amoxicillin, Clavulanic Acid
Tablet
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Antimicrobial
Authorized
2022-05-09
Issued: May 2022 AN: 01361/2020 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Clavaseptin 750 mg palatable tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active substances: Amoxicillin (as amoxicillin trihydrate)……………….……………..………. 600 mg Clavulanic acid (as potassium clavulanate, diluted)………………………...... 150 mg Excipients Iron oxide, brown (E172)………………………………….…..…….………….1.43 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. Oblong, off -white to brownish speckled, scored tablets of about 24 mm. Tablet can be divided into four equal parts. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In dogs: treatment or adjunctive treatment of periodontal infections caused by bacteria susceptible to amoxicillin in combination with clavulanic acid i.e. _ Pasteurella _ spp, _Streptococcus_ spp and _Escherichia coli_. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to penicillins or other substances of the β-lactam group or to any of the excipients. Do not administer to gerbils, guinea pigs, hamsters, rabbits and chinchillas. Do not administer to horses and ruminating animals. Do not use in animals with serious dysfunction of the kidneys accompanied by anuria or oliguria. Do not use in cases of known resistance to the combination of amoxicillin and clavulanic acid. Issued: May 2022 AN: 01361/2020 Page 2 of 6 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals In animals with impaired liver and kidney function, the use of the product should be subject to a benefit/risk evaluation by the veterinary surgeon and the posology evaluated carefully. Caution is advised in the use in small herbivores other than those in 4.3. Use of the product should be based on susceptibility testing. Use of the pro Read the complete document